Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).

Wiita AP, Nambiar A.

Transfusion. 2012 Oct;52(10):2146-54. doi: 10.1111/j.1537-2995.2012.03593.x. Epub 2012 Mar 12.

PMID:
23113654
2.

Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review.

Vassallo RR, Fung M, Rebulla P, Duquesnoy R, Saw CL, Slichter SJ, Tanael S, Shehata N; International Collaboration for Guideline Development, Implementation and Evaluation for Transfusion Therapies.

Transfusion. 2014 Apr;54(4):1180-91. doi: 10.1111/trf.12395. Epub 2013 Aug 27. Review.

PMID:
24032995
3.

Use of HLA- and HPA--matched platelets in alloimmunized patients.

Kekomäki R.

Vox Sang. 1998;74 Suppl 2:359-63. Review.

PMID:
9704468
4.

Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review.

Pavenski K, Rebulla P, Duquesnoy R, Saw CL, Slichter SJ, Tanael S, Shehata N; International Collaboration for Guideline Development, Implementation and Evaluation for Transfusion Therapies (ICTMG) Collaborators.

Transfusion. 2013 Oct;53(10):2230-42. doi: 10.1111/trf.12175. Epub 2013 Apr 3. Review.

PMID:
23550773
5.

Evidence-based platelet transfusion guidelines.

Slichter SJ.

Hematology Am Soc Hematol Educ Program. 2007:172-8. Review.

PMID:
18024626
6.
7.
8.

Platelet transfusions in heparin-induced thrombocytopenia: a report of four cases and review of the literature.

Hopkins CK, Goldfinger D.

Transfusion. 2008 Oct;48(10):2128-32. doi: 10.1111/j.1537-2995.2008.01822.x. Epub 2008 Jul 24. Review.

PMID:
18657085
9.

The challenge of platelet alloimmunization: management and prevention.

Kickler TS.

Transfus Med Rev. 1990 Oct;4(4 Suppl 1):8-18. Review.

PMID:
2134640
10.

Methods for the selection of platelet products for alloimmune-refractory patients.

Kopko PM, Warner P, Kresie L, Pancoska C.

Transfusion. 2015 Feb;55(2):235-44. doi: 10.1111/trf.12921. Epub 2014 Nov 13. Review.

PMID:
25393955
11.

Consequences of transfusion of platelet antibody: a case report and literature review.

Pavenski K, Webert KE, Goldman M.

Transfusion. 2008 Sep;48(9):1981-9. doi: 10.1111/j.1537-2995.2008.01796.x. Epub 2008 Jun 28. Review.

PMID:
18564398
12.

Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: a systematic review.

Heddle NM, Arnold DM, Boye D, Webert KE, Resz I, Dumont LJ.

Transfusion. 2008 Jul;48(7):1447-58. doi: 10.1111/j.1537-2995.2008.01731.x. Epub 2008 May 13. Review.

PMID:
18482183
13.

Clinical aspects of platelet transfusion therapy.

Murphy MF.

Infusionsther Transfusionsmed. 1994 Nov;21 Suppl 3:34-8. Review.

PMID:
7841778
14.

Genetically engineered blood pharming: generation of HLA-universal platelets derived from CD34+ progenitor cells.

Figueiredo C, Blaszczyk R.

J Stem Cells. 2014;9(3):149-61. doi: jsc.2014.9.3.149. Review.

PMID:
25157449
15.

Rituximab, plasma exchange and intravenous immunoglobulins as a new treatment strategy for severe HLA alloimmune platelet refractoriness.

Cid J, Magnano L, Acosta M, Alba C, Esteve J, Lozano M.

Platelets. 2015;26(2):190-4. doi: 10.3109/09537104.2014.895922. Epub 2014 May 27. Review.

PMID:
24867634
16.

Platelet transfusion for patients with cancer.

Fletcher CH, DomBourian MG, Millward PA.

Cancer Control. 2015 Jan;22(1):47-51. Review.

17.

Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility.

Valsami S, Dimitroulis D, Gialeraki A, Chimonidou M, Politou M.

Asian J Transfus Sci. 2015 Jul-Dec;9(2):117-23. doi: 10.4103/0973-6247.162684. Review.

18.

Management of the Platelet Refractory Patient.

Forest SK, Hod EA.

Hematol Oncol Clin North Am. 2016 Jun;30(3):665-77. doi: 10.1016/j.hoc.2016.01.008. Epub 2016 Apr 5. Review.

PMID:
27113003
19.

Refrigerated platelets for the treatment of acute bleeding: a review of the literature and reexamination of current standards.

Pidcoke HF, Spinella PC, Ramasubramanian AK, Strandenes G, Hervig T, Ness PM, Cap AP.

Shock. 2014 May;41 Suppl 1:51-3. doi: 10.1097/SHK.0000000000000078. Review.

PMID:
24662779
20.

Pathology consultation on electronic crossmatch.

Mazepa MA, Raval JS, Park YA; Education Committee of the Academy of Clinical Laboratory Physicians and Scientists.

Am J Clin Pathol. 2014 May;141(5):618-24. doi: 10.1309/AJCPZRQIPGZ2XU4V. Review.

Items per page

Supplemental Content

Write to the Help Desk